Mick Foy | Group Manager of Vigilance Intelligence and Research Group
M.H.R.A.

Mick Foy, Group Manager of Vigilance Intelligence and Research Group, M.H.R.A.

Appearances:



World Drug Safety Europe Day Two (Wednesday 13 September ) @ 09:45

Keynote Panel discussion: Updates on European pharmacovigilance regulation and their implications for the industry

Master Drug Safety EU
  • Achieving greater collaboration with medicines regulators across Europe and ensuring a smoother launch of new products
  • Examining developments in GVP measures and status of the new Module VI
  • Managing and reporting of adverse reactions to medicinal products
Mick Foy, Group Manager of Vigilance Intelligence and Research Group, M.H.R.A.
Doris Stenver, Chief Medical Officer, member of PRAC at EMA, Danish Medicines Agency
Shelly Goodman, Head of Global Pharmacovigilance and Drug Safety, Portola Pharmaceuticals , Inc.
Liana Gross Martirosyan, Pharmacovigilance Assessor, Dutch Medicines Evaluation Board

back to speakers